Cat.#: ACPP-1547
Despition | CA14 Human Recombinant |
SIZE | 5 µg |
Purity | > 85.0% (SDS-PAGE) |
Form | Sterile Filtered colorless solution. |
Storage | Lyophilized was stored at -20°C to -80°C, while reconstituted was aliquot and stored at -80°C. Avoid freeze/thaw cycles. |
Shipping | Shipped at 4°C |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ACPP-1080 | GABA B Receptor 2 Blocking Peptide (AC1080) | 250 µg | inquiry |
ACPP-1613 | Human RAB3IL1 Protein (AC1613) | 2 µg | inquiry |
ACPP-1266 | ROR1 Blocking Peptide (AC1266) | 250 µg | inquiry |
ACPP-1290 | Insulin Receptor Blocking Peptide (AC1290) | 250 µg | inquiry |
ACPP-1338 | Dopamine Receptor D1 Blocking Peptide (AC1338) | 250 µg | inquiry |
ACPP-1560 | Human RBM17 Protein (AC1560) | 2 µg | inquiry |
ACPP-1134 | Recombinant Mouse ROR1 Protein (6×His Tag) (AC1134) | 50 µg | inquiry |
ACPP-1682 | Human CALB1 Protein (AC1682) | 10 µg | inquiry |
ACPP-1724 | Human FGF13 Protein (AC1724) | 5 µg | inquiry |
ACPP-1554 | Human Human FGF1 (Active) Protein (AC1554) | 500U | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.